Atlas Trials

Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease

Clinical trial NCT00225173 · TERMINATED

Trial details

NCT number
NCT00225173
Sponsor
Stanford University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hodgkin Disease
Start date
2001-10-01
Primary completion
2005-09-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.